Nacalai USA Inc San Diego, CA - 92121

Nacalai USA Inc is categorized under Commercial Biotechnical Research in San Diego, CA and active since 2005.

Nacalai USA Inc was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 5417114 by the NAICS.

If you are seeking more information, feel free to contact Toshi Ono, Vice President at the company’s single location by writing to 10225 Barnes Canyon Road # 103, San Diego, California CA 92121 or by phoning (858) 404-0403. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Nacalai USA Inc
Contact Person: Toshi Ono, Vice President
Address: 10225 Barnes Canyon Road # 103, San Diego, California 92121
Phone Number: (858) 404-0403
Website Address: nacalaiusa.com
Annual Revenue (USD): Unknown
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 5417114
Share This Business:

Nacalai USA Inc was started in 2005 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 5417114. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Toshi Ono, Vice President for inquiries that concern Nacalai USA Inc by calling the company number (858) 404-0403, as your correspondence is most welcome. Additionally, the physical location of the single location of Nacalai USA Inc can be found at the coordinates 32.899867,-117.19681 as well as the street address 10225 Barnes Canyon Road # 103 in San Diego, California 92121.

For its online presence, you may visit Nacalai USA Inc’s website at nacalaiusa.com and engage with its social media outlets through on Twitter and on Facebook.